Questcor Pharmaceuticals Stock Price, News & Analysis (NASDAQ:QCOR)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Questcor Pharmaceuticals (NASDAQ:QCOR)

Questcor Pharmaceuticals logoQuestcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.

Receive QCOR News and Ratings via Email

Sign-up to receive the latest news and ratings for QCOR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Questcor Pharmaceuticals (NASDAQ:QCOR) Frequently Asked Questions

What is Questcor Pharmaceuticals' stock symbol?

Questcor Pharmaceuticals trades on the NASDAQ under the ticker symbol "QCOR."

Who are some of Questcor Pharmaceuticals' key competitors?

Has Questcor Pharmaceuticals been receiving favorable news coverage?

News coverage about QCOR stock has trended positive recently, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Questcor Pharmaceuticals earned a media sentiment score of 0.39 on Accern's scale. They also gave media coverage about the biopharmaceutical company an impact score of 45.19 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Questcor Pharmaceuticals?

Shares of QCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Questcor Pharmaceuticals?

Questcor Pharmaceuticals' mailing address is 1300 N Kellogg Dr Ste D, ANAHEIM, CA 92807-1965, United States. The biopharmaceutical company can be reached via phone at +1-714-7864200.

MarketBeat Community Rating for Questcor Pharmaceuticals (QCOR)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  284 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  401
MarketBeat's community ratings are surveys of what our community members think about Questcor Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Questcor Pharmaceuticals (NASDAQ:QCOR) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Questcor Pharmaceuticals (NASDAQ:QCOR) Earnings History and Estimates Chart

Earnings by Quarter for Questcor Pharmaceuticals (NASDAQ:QCOR)

Questcor Pharmaceuticals (NASDAQ QCOR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2014Q214$1.74$1.85$261.02 million$278.80 millionViewN/AView Earnings Details
4/28/2014Q114$1.61$1.40$239.81 million$227.10 millionViewN/AView Earnings Details
2/25/2014Q413$1.66$1.67$244.15 million$243.00 millionViewN/AView Earnings Details
10/29/2013Q313$1.29$1.52$199.70 million$236.35 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.96$1.12$168.96 million$184.60 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.96$0.76$157.68 million$135.13 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.90$1.03$142.58 million$160.50 millionViewN/AView Earnings Details
10/23/2012$0.74$0.91ViewN/AView Earnings Details
7/24/2012$0.63$0.65ViewN/AView Earnings Details
4/24/2012Q1 2012$0.50$0.58ViewN/AView Earnings Details
2/22/2012$0.41$0.47ViewN/AView Earnings Details
10/25/2011$0.26$0.37ViewN/AView Earnings Details
7/26/2011Q2 2011$0.18$0.21ViewN/AView Earnings Details
4/26/2011$0.17$0.20ViewN/AView Earnings Details
2/23/2011$0.15$0.12ViewN/AView Earnings Details
10/28/2010Q3 2010$0.14$0.18ViewN/AView Earnings Details
7/28/2010Q2 2010$0.14$0.14ViewN/AView Earnings Details
4/29/2010Q1 2010$0.13$0.12ViewN/AView Earnings Details
3/1/2010Q4 2009$0.09$0.13ViewN/AView Earnings Details
11/2/2009Q3 2009$0.11$0.02ViewN/AView Earnings Details
7/29/2009Q2 2009$0.14$0.14ViewN/AView Earnings Details
4/28/2009Q1 2009$0.14$0.11ViewN/AView Earnings Details
2/24/2009Q4 2008$0.14$0.17ViewN/AView Earnings Details
10/30/2008Q3 2008$0.10$0.13ViewN/AView Earnings Details
7/24/2008Q2 2008$0.10$0.12ViewN/AView Earnings Details
4/30/2008Q1 2008$0.02ViewN/AView Earnings Details
3/3/2008Q4 2007$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Questcor Pharmaceuticals (NASDAQ:QCOR) Earnings Estimates

No earnings estimates for this company have been tracked by


Questcor Pharmaceuticals (NASDAQ:QCOR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Questcor Pharmaceuticals (NASDAQ QCOR) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Questcor Pharmaceuticals (NASDAQ:QCOR)

Questcor Pharmaceuticals (NASDAQ QCOR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/13/2014Don M BaileyInsiderSell40,000$91.96$3,678,400.00View SEC Filing  
8/11/2014Michael H MulroyInsiderSell10,000$92.33$923,300.00View SEC Filing  
7/14/2014Don M BaileyInsiderSell40,000$95.54$3,821,600.00View SEC Filing  
7/10/2014Michael H MulroyInsiderSell10,000$90.89$908,900.00View SEC Filing  
6/24/2014David YoungInsiderSell6,000$91.96$551,760.00View SEC Filing  
6/13/2014Don M BaileyCEOSell40,000$89.83$3,593,200.00View SEC Filing  
6/10/2014Michael H MulroyInsiderSell10,000$88.57$885,700.00View SEC Filing  
5/19/2014David Jeffrey MedeirosEVPSell2,292$89.66$205,500.72120,039View SEC Filing  
5/13/2014Don BaileyCEOSell40,000$87.05$3,482,000.00View SEC Filing  
5/12/2014Michael MulroyInsiderSell10,000$87.99$879,900.0077,063View SEC Filing  
4/21/2014David Jeffrey MedeirosEVPSell2,292$77.15$176,827.80120,039View SEC Filing  
4/14/2014Don BaileyCEOSell40,000$79.65$3,186,000.00View SEC Filing  
4/10/2014Michael MulroyInsiderSell10,000$85.04$850,400.0077,063View SEC Filing  
4/7/2014Stephen FarrellDirectorSell10,000$81.43$814,300.0020,433View SEC Filing  
3/17/2014David Jeffrey MedeirosEVPSell2,291$62.61$143,439.51120,039View SEC Filing  
3/14/2014David YoungInsiderSell6,000$62.28$373,680.00111,741View SEC Filing  
3/13/2014Don BaileyCEOSell40,000$62.71$2,508,400.00View SEC Filing  
3/10/2014Michael MulroyInsiderSell10,000$64.80$648,000.0077,063View SEC Filing  
2/25/2014Broadwood Partners LpDirectorSell83,600$79.59$6,653,724.00View SEC Filing  
2/20/2014Broadwood Partners LpDirectorSell306,400$74.94$22,961,616.00View SEC Filing  
2/12/2014Broadwood Partners LpDirectorSell85,000$69.10$5,873,500.00View SEC Filing  
1/30/2014Broadwood Partners LpDirectorSell50,000$66.55$3,327,500.00View SEC Filing  
1/24/2014David YoungInsiderSell6,000$64.38$386,280.0091,145View SEC Filing  
1/23/2014Broadwood Partners LpDirectorSell20,000$65.00$1,300,000.00View SEC Filing  
1/23/2014David Jeffrey MedeirosEVPSell133,541$64.91$8,668,146.31118,051View SEC Filing  
1/16/2014David Jeffrey MedeirosEVPSell50,000$62.00$3,100,000.00118,051View SEC Filing  
1/13/2014Don BaileyCEOSell40,000$53.64$2,145,600.00View SEC Filing  
11/14/2013Neal BradsherDirectorSell40,000$62.41$2,496,400.00View SEC Filing  
11/13/2013Broadwood Partners LpDirectorSell500,000$62.37$31,185,000.00View SEC Filing  
10/14/2013Don BaileyCEOSell40,000$62.16$2,486,400.00View SEC Filing  
10/14/2013Virgil ThompsonDirectorSell2,500$60.50$151,250.0029,867View SEC Filing  
9/16/2013Virgil ThompsonDirectorSell5,000$63.75$318,750.0029,867View SEC Filing  
9/13/2013Don BaileyCEOSell40,000$63.69$2,547,600.00View SEC Filing  
8/26/2013David Jeffrey MedeirosEVPSell55,000$73.98$4,068,900.00117,121View SEC Filing  
8/14/2013Virgil ThompsonDirectorSell5,000$69.12$345,600.0029,867View SEC Filing  
8/13/2013David Jeffrey MedeirosEVPSell110,597$67.85$7,504,006.45117,121View SEC Filing  
8/6/2013David Jeffrey MedeirosEVPSell58,831$66.69$3,923,439.39117,121View SEC Filing  
7/15/2013Don M BaileyCEOSell33,339$49.31$1,643,946.09View SEC Filing  
7/15/2013Virgil D ThompsonDirectorSell5,000$49.29$246,450.00View SEC Filing  
6/14/2013Virgil D ThompsonDirectorSell5,000$45.55$227,750.00View SEC Filing  
6/13/2013Don M BaileyCEOSell40,000$45.01$1,800,400.00View SEC Filing  
5/14/2013Don M BaileyCEOSell180,000$40.14$7,225,200.00View SEC Filing  
5/14/2013Virgil D ThompsonDirectorSell5,000$37.46$187,300.00View SEC Filing  
5/9/2013Virgil D ThompsonDirectorSell2,187$35.00$76,545.00View SEC Filing  
3/21/2013Virgil D ThompsonDirectorSell47,500$35.00$1,662,500.00View SEC Filing  
11/5/2012David Jeffrey MedeirosEVPBuy55,000$23.92$1,315,600.00View SEC Filing  
11/2/2012Stephen Lahue CarttVPBuy10,000$24.17$241,700.00View SEC Filing  
9/4/2012Mitchell J Md BluttDirectorSell24,730$47.60$1,177,148.00View SEC Filing  
(Data available from 1/1/2013 forward)


Questcor Pharmaceuticals (NASDAQ QCOR) News Headlines


SEC Filings

Questcor Pharmaceuticals (NASDAQ:QCOR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Questcor Pharmaceuticals (NASDAQ:QCOR) Income Statement, Balance Sheet and Cash Flow Statement


Questcor Pharmaceuticals (NASDAQ QCOR) Stock Chart for Wednesday, March, 21, 2018

Loading chart…

This page was last updated on 3/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.